Literature DB >> 9672064

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.

D S Freedman1, J D Otvos, E J Jeyarajah, J J Barboriak, A J Anderson, J A Walker.   

Abstract

Although each of the major lipoprotein fractions is composed of various subclasses that may differ in atherogenicity, the importance of this heterogeneity has been difficult to ascertain owing to the labor-intensive nature of subclass measurement methods. We have recently developed a procedure, using proton nuclear magnetic resonance (NMR) spectroscopy, to simultaneously quantify levels of subclasses of very low density (VLDL), low density (LDL), and high density (HDL) lipoproteins; subclass distributions determined with this method agree well with those derived by gradient gel electrophoresis. The objective of the current study of 158 men was to examine whether NMR-derived lipoprotein subclass levels improve the prediction of arteriographically documented coronary artery disease (CAD) when levels of lipids and lipoproteins are known. We found that a global measure of CAD severity was positively associated with levels of large VLDL and small HDL particles and inversely associated with intermediate size HDL particles; these associations were independent of age and standard lipid measurements. At comparable lipid and lipoprotein levels, for example, men with relatively high (higher than the median) levels of either small HDL or large VLDL particles were three to four times more likely to have extensive CAD than were the other men; the 27 men with high levels of both large VLDL and small HDL were 15 times more likely to have extensive CAD than were men with low levels. In contrast, adjustment for levels of triglycerides or HDL cholesterol greatly reduced the relation of small LDL particles to CAD. These findings suggest that large VLDL and small HDL particles may play important roles in the development of occlusive disease and that their measurement, which is not possible with routine lipid testing, may lead to more accurate risk assessment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672064     DOI: 10.1161/01.atv.18.7.1046

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  87 in total

1.  A "natural experiment" in cardiovascular epidemiology in the early 21st century.

Authors:  A Sekikawa; B Y Horiuchi; D Edmundowicz; H Ueshima; J D Curb; K Sutton-Tyrrell; T Okamura; T Kadowaki; A Kashiwagi; K Mitsunami; K Murata; Y Nakamura; B L Rodriguez; L H Kuller
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

Review 2.  The physiology of lipoproteins.

Authors:  Thomas N Tulenko; Anne E Sumner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

Review 3.  Specialized lipid profiles.

Authors:  Karen E Friday
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 4.  Low-density lipoprotein particle number and risk for cardiovascular disease.

Authors:  William C Cromwell; James D Otvos
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

Review 5.  High-density lipoprotein subfractions and risk of coronary artery disease.

Authors:  John Morgan; Christina Carey; Anne Lincoff; David Capuzzi
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

6.  Comparison of analytical mathematical approaches for identifying key nuclear magnetic resonance spectroscopy biomarkers in the diagnosis and assessment of clinical change of diseases.

Authors:  Jason B Nikas; C Dirk Keene; Walter C Low
Journal:  J Comp Neurol       Date:  2010-10-15       Impact factor: 3.215

Review 7.  Biomarkers and HIV-associated cardiovascular disease.

Authors:  Jason V Baker; Daniel Duprez
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

8.  Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome.

Authors:  R Scott Rector; Shana O Warner; Ying Liu; Pamela S Hinton; Grace Y Sun; Richard H Cox; Craig S Stump; M Harold Laughlin; Kevin C Dellsperger; Tom R Thomas
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-05-01       Impact factor: 4.310

9.  High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.

Authors:  Jason Baker; Woubeshet Ayenew; Harrison Quick; Katherine Huppler Hullsiek; Russell Tracy; Keith Henry; Daniel Duprez; James D Neaton
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

10.  Pleiotropic effects on subclasses of HDL, adiposity, and glucose metabolism in adult Alaskan Eskimos.

Authors:  M Elizabeth Tejero; V S Voruganti; Guowen Cai; Shelley A Cole; Sandra Laston; Charlotte R Wenger; Jean W Mac Cluer; Bennet Dyke; Richard Devereux; Sven O Ebbesson; Richard R Fabsitz; B V Howard; A G Comuzzie
Journal:  Am J Hum Biol       Date:  2010 Jul-Aug       Impact factor: 1.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.